60岁女性,左上腹肿物
病理诊断:去分化脂肪肉瘤(Dedifferentiated liposarcoma)
MDM2( )
p16( )
p16( )
Soft Tissue and Bone Tumours
(WHO 5, 2020)
去分化脂肪肉瘤(Dedifferentiated liposarcoma)
-
ICD-O编码:8858/3
-
由非典型脂肪瘤样肿瘤/高分化脂肪肉瘤,在原发或复发过程中,进展为不同组织学级别的肉瘤(通常为非脂肪源性)
-
大多数病例存在MDM2和CDK4基因扩增
-
高分化脂肪肉瘤的成分可能难以识别(不明显)
Dedifferentiated liposarcoma

Abrupt transition from well-differentiated liposarcoma to highgrade non-lipogenic pleomorphic sarcoma is seen.
-
去分化脂肪肉瘤:高分化脂肪肉瘤突然转变为高级别非脂肪源性多形性肉瘤
Interphase FISH analysis using probes for MDM2 (green signals) and centromere 12 (red signals) showing high-level amplification of MDM2. The amplified signals are grouped in a large cluster, representative of the presence of a supernumerary ring or giant marker chromosome. The three coupled red-green signals indicate trisomy 12.
-
采用针对MDM2基因(绿色信号)和12号染色体着丝粒(红色信号)的探针进行间期荧光原位杂交(FISH)分析,显示MDM2基因存在高度扩增
-
扩增信号聚集形成大簇状分布(正常细胞为2个绿色信号),提示存在额外的环状染色体或巨型标记染色体
-
三红三绿信号提示12号染色体三体(trisomy)
文献复习
-
难以通过形态学区分高分化脂肪肉瘤/非典型脂肪瘤样肿瘤与良性脂肪病变(特别是深部脂肪瘤)
-
高分化及去分化脂肪肉瘤:
-
p16核阳性(单独使用或与CDK4和MDM2联合)具有诊断价值
-
p16阳性 CDK4阳性:非常敏感且特异
-
良性脂肪瘤:p16(-)
-
诊断陷阱⚠️:脂肪坏死区域可能出现p16核表达,特别是深部脂肪瘤
A well-differentiated liposarcoma displaying nuclear p16 immunoreactivity.
-
高分化脂肪肉瘤:p16(核 )